UnlockOptinose names Terry Kohler as new CFO
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OptiNose (OPTN)
NASDAQ
Currency in USD
Disclaimer
0.710
+0.040(+5.91%)
Closed
After Hours
0.676-0.034(-4.817%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.658
0.712
52 wk Range
0.650
2.100
OPTN Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
"OptiNose stock price live, this page displays NASDAQ OPTN stock exchange data. View the OPTN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OptiNose real time stock price chart below.
What Is the OptiNose Stock Price Today?
The OptiNose stock price today is 0.710.
What Is the Stock Symbol for OptiNose?
The stock symbol for OptiNose is ""OPTN.""
What Stock Exchange Does OptiNose Trade On?
OptiNose is listed and trades on the NASDAQ stock exchange.
Is OptiNose a Good Stock to Buy?
Determining whether OptiNose—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPTN quote. (ISIN: US68404V1008)"
What Is the OptiNose Stock Price Today?
The OptiNose stock price today is 0.710.
What Is the Stock Symbol for OptiNose?
The stock symbol for OptiNose is ""OPTN.""
What Stock Exchange Does OptiNose Trade On?
OptiNose is listed and trades on the NASDAQ stock exchange.
Is OptiNose a Good Stock to Buy?
Determining whether OptiNose—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPTN quote. (ISIN: US68404V1008)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6580.712
52 wk Range
0.6502.100
OPTN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
3.500
Upside
+392.958%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- OptiNose Appoints Terry Kohler as CFO
- Investing.com
- Optinose CEO sells over $4,000 in company stock
- Investing.com
- Optinose names Terry Kohler as new CFO
- Investing.com
- OptiNose Appoints Terry Kohler as CFO
- Investing.com
- OptiNose announces board member resignation
- Investing.com
OptiNose Company Profile
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.
Compare OPTN to Peers and Sector
Metrics to compare | OPTN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPTNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.6x | −0.7x | −0.6x | |
PEG Ratio | −0.10 | 0.00 | 0.00 | |
Price/Book | −2.5x | 2.2x | 2.6x | |
Price / LTM Sales | 1.4x | 1.6x | 3.2x | |
Upside (Analyst Target) | 322.5% | 51.1% | 46.9% | |
Fair Value Upside | Unlock | 17.0% | 7.9% | Unlock |
FAQ
What Is the OptiNose (OPTN) Stock Price Today?
The OptiNose stock price today is 0.71
What Stock Exchange Does OptiNose Trade On?
OptiNose is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for OptiNose?
The stock symbol for OptiNose is "OPTN."
What Is the OptiNose Market Cap?
As of today, OptiNose market cap is 103.73M.
What is OptiNose Earnings Per Share?
The OptiNose EPS is -0.338.
What Is the Next OptiNose Earnings Date?
OptiNose will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.